Literature DB >> 8039485

Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer.

R A Goldbohm1, P A van den Brandt, H A Brants, P van't Veer, M Al, F Sturmans, R J Hermus.   

Abstract

OBJECTIVE: The study was conducted to assess the validity of a self-administered 150-item food frequency questionnaire (FFQ), used in a cohort study on diet and cancer (120,852 men and women, aged 55-69). DESIGN &
SUBJECTS: The study was carried out in a subgroup of the cohort (59 men and 50 women) 2 years after the baseline FFQ was completed. A dietary record, kept over three 3-day periods, 4-5 months apart, served as reference method. To evaluate the representativeness of the study population for the entire cohort, a comparison was made with the baseline questionnaire of a random sample of the cohort.
RESULTS: Pearson correlation coefficients between nutrient intakes assessed by the record and the FFQ that was completed afterwards ranged from 0.40 (95% CI: 0.22-0.54) for vitamin B1 to 0.86 (95% CI: 0.80-0.90) for alcohol intake, with correlations for most nutrients between 0.6 and 0.8. Adjustment for energy intake and sex did not materially affect these correlations, except the correlation for fat intake, which changed from 0.72 to 0.52. Correlation coefficients were only slightly modified when the results were extrapolated to the cohort at large. Correction of correlation coefficients for attenuation by day-to-day variance in the record data improved them by 0.07 on average.
CONCLUSIONS: It is concluded that the FFQ is able to rank subjects according to intake of food groups and nutrients. Despite a better performance of validation study participants, this conclusion also applies to the cohort at large.

Entities:  

Mesh:

Year:  1994        PMID: 8039485

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  103 in total

1.  Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies.

Authors:  Xuehong Zhang; Demetrius Albanes; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Andrew Flood; Jo L Freudenheim; Edward L Giovannucci; R Alexandra Goldbohm; Karen Jaceldo-Siegl; Eric J Jacobs; Vittorio Krogh; Susanna C Larsson; James R Marshall; Marjorie L McCullough; Anthony B Miller; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Sabina Sieri; Donna Spiegelman; Jarmo Virtamo; Alicja Wolk; Walter C Willett; Shumin M Zhang; Stephanie A Smith-Warner
Journal:  J Natl Cancer Inst       Date:  2010-05-07       Impact factor: 13.506

2.  Socioeconomic status and lung cancer incidence in men in The Netherlands: is there a role for occupational exposure?

Authors:  A J van Loon; R A Goldbohm; I J Kant; G M Swaen; A M Kremer; P A van den Brandt
Journal:  J Epidemiol Community Health       Date:  1997-02       Impact factor: 3.710

3.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

4.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

5.  Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements.

Authors:  Sarah Rosner Preis; Donna Spiegelman; Barbara Bojuan Zhao; Alanna Moshfegh; David J Baer; Walter C Willett
Journal:  Am J Epidemiol       Date:  2011-02-22       Impact factor: 4.897

6.  Validity of observed differences in dietary surveys by two self-administered questionnaires over a 5-year period: Concordance with self-reported change.

Authors:  K Ozasa; A Higashi; M Yamasaki; K Hayashi; Y Watanabe
Journal:  Environ Health Prev Med       Date:  1997-07       Impact factor: 3.674

7.  A Pooled Analysis of 15 Prospective Cohort Studies on the Association between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer.

Authors:  Joshua Petimar; Kathryn M Wilson; Kana Wu; Molin Wang; Demetrius Albanes; Piet A van den Brandt; Michael B Cook; Graham G Giles; Edward L Giovannucci; Gary E Goodman; Phyllis J Goodman; Niclas Håkansson; Kathy Helzlsouer; Timothy J Key; Laurence N Kolonel; Linda M Liao; Satu Männistö; Marjorie L McCullough; Roger L Milne; Marian L Neuhouser; Yikyung Park; Elizabeth A Platz; Elio Riboli; Norie Sawada; Jeannette M Schenk; Shoichiro Tsugane; Bas Verhage; Ying Wang; Lynne R Wilkens; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-26       Impact factor: 4.254

8.  Lung cancer: is there an association with socioeconomic status in The Netherlands?

Authors:  A J van Loon; R A Goldbohm; P A van den Brandt
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

9.  Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms.

Authors:  Laura A E Hughes; Piet A van den Brandt; Adriaan P de Bruïne; Kim A D Wouters; Sarah Hulsmans; Angela Spiertz; R Alexandra Goldbohm; Anton F P M de Goeij; James G Herman; Matty P Weijenberg; Manon van Engeland
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

10.  Relationship between tap water hardness, magnesium, and calcium concentration and mortality due to ischemic heart disease or stroke in The Netherlands.

Authors:  Lina J Leurs; Leo J Schouten; Margreet N Mons; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Environ Health Perspect       Date:  2009-10-26       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.